Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Humana to study adverse reactions
In an unprecedented initiative, the University of Miami and Humana are joining forces to study drug safety and adverse reactions. Researchers will track Humana's database of 11 million members, looking for dangerous side effects that become apparent only after a drug has been used for some time. Dubbed the Pharmacovigilance Initiative, the program is an attempt to reach beyond voluntary reporting of adverse drug reactions. Results will be reported publicly via press releases and a special website beginning in 2008.
- check out the release on the program
- here's the report on the initiative from the South Florida Business Journal
Related Articles:
Humana, University of Miami take on 'pre-sick.' Report
Pharmacovigilance grows in importance. Report
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


